Abnova Taiwan (Taiwan) Insiders
4133 Stock | TWD 31.15 0.10 0.32% |
Abnova Taiwan employs about 14 people. The company is managed by 14 executives with a total tenure of roughly 190 years, averaging almost 13.0 years of service per executive, having 1.0 employees per reported executive. Recap of Abnova Taiwan's management performance can provide insight into the venture performance.
Wilber Huang Director General Manager, Director |
Qijing Qiu Director Director |
Abnova |
Abnova Taiwan Management Team Effectiveness
The company has return on total asset (ROA) of 0.0227 % which means that it generated a profit of $0.0227 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0505 %, meaning that it generated $0.0505 on every $100 dollars invested by stockholders. Abnova Taiwan's management efficiency ratios could be used to measure how well Abnova Taiwan manages its routine affairs as well as how well it operates its assets and liabilities.Abnova Taiwan Workforce Comparison
Abnova Taiwan Corp is rated below average in number of employees category among related companies. The total workforce of Health Care industry is presently estimated at about 130. Abnova Taiwan retains roughly 14.0 in number of employees claiming about 11% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.12 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.12. Abnova Taiwan Corp Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Abnova Taiwan Corp Price Series Summation is a cross summation of Abnova Taiwan price series and its benchmark/peer.
Abnova Taiwan Notable Stakeholders
An Abnova Taiwan stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Abnova Taiwan often face trade-offs trying to please all of them. Abnova Taiwan's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Abnova Taiwan's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Wilber Huang | General Manager, Director | Profile | |
Qijing Qiu | Director | Profile | |
Heyuan Chen | Director | Profile | |
Ruilin Chen | Independent Director | Profile | |
Shengyi Su | Director | Profile | |
Huanxin Li | Director | Profile | |
Hesong Wang | Independent Director | Profile | |
Yurui Chen | Independent Director | Profile | |
Yiting Li | Director | Profile | |
Shukuan Chen | Executive Deputy General Manager, Director | Profile | |
Xinhui Lin | Deputy General Manager | Profile | |
Menghong Chen | Head of Finance & Accounting | Profile | |
Yihuang Huang | Head of Finance & Accounting | Profile | |
Hanwen Guan | Deputy General Manager | Profile |
About Abnova Taiwan Management Performance
The success or failure of an entity such as Abnova Taiwan Corp often depends on how effective the management is. Abnova Taiwan management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Abnova management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Abnova management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Abnova Corporation manufactures and sells various recombinant proteins and antibodies. Abnova Corporation is headquartered in Taipei, Taiwan. ABNOVA CORPORATION operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.
The data published in Abnova Taiwan's official financial statements usually reflect Abnova Taiwan's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Abnova Taiwan Corp. For example, before you start analyzing numbers published by Abnova accountants, it's critical to develop an understanding of what Abnova Taiwan's liquidity, profitability, and earnings quality are in the context of the Life Sciences Tools & Services space in which it operates.
Please note, the presentation of Abnova Taiwan's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Abnova Taiwan's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Abnova Taiwan's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Abnova Taiwan Corp. Please utilize our Beneish M Score to check the likelihood of Abnova Taiwan's management manipulating its earnings.
Abnova Taiwan Workforce Analysis
Traditionally, organizations such as Abnova Taiwan use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Abnova Taiwan within its industry.Abnova Taiwan Manpower Efficiency
Return on Abnova Taiwan Manpower
Revenue Per Employee | 32.2M | |
Revenue Per Executive | 32.2M | |
Net Income Per Employee | 2M | |
Net Income Per Executive | 2M | |
Working Capital Per Employee | 60.6M | |
Working Capital Per Executive | 60.6M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abnova Taiwan Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Abnova Stock analysis
When running Abnova Taiwan's price analysis, check to measure Abnova Taiwan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abnova Taiwan is operating at the current time. Most of Abnova Taiwan's value examination focuses on studying past and present price action to predict the probability of Abnova Taiwan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abnova Taiwan's price. Additionally, you may evaluate how the addition of Abnova Taiwan to your portfolios can decrease your overall portfolio volatility.
Global Correlations Find global opportunities by holding instruments from different markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |